Navigation Links
Raj Khankari Named Bioenergy, Inc., CEO
Date:7/16/2008

MINNEAPOLIS, July 16 /PRNewswire/ -- In a statement released today, Bud Hayden, a director serving as interim CEO of Bioenergy, Inc., a privately held Minneapolis-based integrative life science company, announced Raj Khankari, PhD, will join the company as its new CEO on August 1, 2008.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080716/AQW501)

Dr. Khankari joins the company from CIMA Labs Inc., a Cephalon company, where he served as General Manager, CIMA Labs Inc., and Vice President for Worldwide Drug Delivery Technologies. Dr. Khankari earned his initial degrees in Pharmaceutics from universities in India. Dr. Khankari also has a PhD in Pharmaceutics and an MBA from the University of Minnesota.

In addition to holding several patents, Dr. Khankari has been widely published in several peer reviewed journals and has been a presenter at more than two dozen national and international meetings.

In making the announcement, Mr. Hayden stated, "We are very pleased to have Dr. Khankari head up our Company. His scientific background, including his successful track record in working with the Food and Drug Administration (FDA) on new product discoveries, in conjunction with the experience he gained in holding senior management positions, will provide the leadership Bioenergy needs to take advantage of our strong intellectual property portfolio."

In addition to its pharmaceutical subsidiary company, Bioenergy has two other subsidiaries. Bioenergy Life Science, Inc. manufactures and sells D-ribose as an ingredient to nutraceuticals firms marketing beverages and foods, as a medical food through doctors and clinics and as a dietary supplement for energy recovery (reduces fatigue, muscle pain, soreness and stiffness following exercise). Viacell, LLC is engaged in developing technology related to the enhancement of blood components.

D-Ribose is a natura
'/>"/>

SOURCE Bioenergy, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Samarion CEO Mark Rodgers Named CAST Commissioner
2. North Carolina Marketing Firm MicroMass Named One of Top 60 Healthcare Agencies in U.S.
3. Quintiles Named to Computerworld Magazines 100 Best Places to Work in Information Technology List
4. WuXi PharmaTech (NYSE: WX) Named the Most Innovative Company in China and CEO Dr. Li the Most Innovative Leader of Chinese Enterprises
5. Agensys Founder, President, & CEO Dr. Donald Rice Named Ernst & Young Entrepreneur Of The Year(R) 2008 Award Winner for the Greater Los Angeles Area
6. Tolerx Named as One of the Fierce 15 Biotech Companies of 2008
7. Brian Levy, OD, MSc, Named Chief Operating Officer of Danube Pharmaceuticals
8. Barrett Katz, MD, MBA, Named CEO of Danube Pharmaceuticals
9. Ten Latin American Scientists Named 2008 Pew Fellows in the Biomedical Sciences
10. Netsmarts Kevin Scalia Named Chair of the Software and Technology Vendors Association
11. GlaxoSmithKline Named A Top Employer for Promoting Healthy Lifestyles

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...,, TORONTO, Nov. 6 /PRNewswire-FirstCall/ - Mic...day that it has re-filed the Form 52-109F1 Certifi...ief Executive Officer and James Long, the Chief Fi...ed January 12, 2009 in connection with the annual ...ptember 30, 2008. ,, The Company initially file...
(Date:11/6/2009)...,, QUINCY, Mass., Nov. 6 Myrian...biotech developer and manufacturer of renewable b...preferred technology provider Uhde GmbH, one of th... "Uhde"), announced an alliance for the engineerin...,s biobased Succinic Acid plants based on renewabl...
(Date:11/6/2009)...,, SPRING VALLEY, Calif., Nov. 6 /PRNewswire/ -...n awarded a Small Business Innovative Research (SB...arch and Material command. Under terms of the agre...agents (ASRs) for the diagnosis of Dengue virus. ... that represents a major threat to military forces...
(Date:11/6/2009)... The agenda for Arrowhead...onference, which is set to take place on February ...t this three day conference we will highlight key ... speakers to share their experiences. , ... 2009 -- The agenda for Arrowhead’s 2010 Pe...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3
... This release is available in French . , An N...laid the groundwork for a lithium battery that can... of conventional lithium ion batteries. , The re...dent David Xiulei Ji and postdoctoral fellow Kyu T...electrochemical performance for a lithium-sulphur ...
... SEATTLE, May 18 /PRNewswire-FirstCall/ - Oncothyr...ced the presentation of data demonstrating the eff...l model of pulmonary fibrosis. The data were prese...ociate Professor, Pulmonary Medicine, Children,s H...merican Thoracic Society International Conference ...
... Non-Profit Biotech Calls on the Entire ALS Commun...ay Events , , CAMBRIDGE, Mass., May 18 The ALS ...its BBQ For ALS Awareness , is a national initiat...anding of ALS (amyotrophic lateral sclerosis), oth...h its goal, the campaign brings together three und...
Other Biology Technology:Canadian research team reports major breakthrough in lithium battery technology 2Oncothyreon's PX-866 is effective in preclinical model of pulmonary fibrosis 2Oncothyreon's PX-866 is effective in preclinical model of pulmonary fibrosis 3Campaign to Increase the Awareness and Understanding of Lou Gehrig's Disease Reaches 22 U.S. States 2Campaign to Increase the Awareness and Understanding of Lou Gehrig's Disease Reaches 22 U.S. States 3
(Date:11/4/2009)... DigitalPersona, Inc., a leader in ... today announced that WAND Corporation, a leading ...-service restaurants, has integrated DigitalPerson...S solutions. WAND,s quick-service customers can no...untability and deter unauthorized manager override...
(Date:11/4/2009)...re/ -- What,s the cost of saving a teenage life? W...ing from prescription medication abuse, there,s no... may be unaware that the lock-boxes they,ve instal...g timebomb of prescription drugs. That,s why MEDNE...l supplies, has formed an exclusive partnership wi...
(Date:11/4/2009)...e-FirstCall/ -- BIO-key International, Inc. (OTC B...metric identification software is showcasing donor...onference being held at the New Orleans Convention...ide hands-on product demonstrations of its state-o... Also, at 5 PM on Monday, October 26, Peter Lux, m...
Breaking Biology News(10 mins):WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 3MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3BIO-key(R) International Exhibiting at AABB TXPO 2Ohio Law Firm Warns of Birth Control Pill YAZ Yasmin Side Effects Lawsuits 54279 1Ohio Law Firm Warns of Birth Control Pill YAZ Yasmin Side Effects Lawsuits 54279 2Ohio Law Firm Warns of Birth Control Pill YAZ Yasmin Side Effects Lawsuits 54279 3Ohio Law Firm Warns of Birth Control Pill YAZ Yasmin Side Effects Lawsuits 54279 4Mysterious charge transport in self assembled monolayer transistors unraveled 13515 1Mysterious charge transport in self assembled monolayer transistors unraveled 13515 2Emdeon Inc Prices Initial Public Offering of Class A Common Stock at 2415 50 Per Share 54275 1Emdeon Inc Prices Initial Public Offering of Class A Common Stock at 2415 50 Per Share 54275 2Emdeon Inc Prices Initial Public Offering of Class A Common Stock at 2415 50 Per Share 54275 3Emdeon Inc Prices Initial Public Offering of Class A Common Stock at 2415 50 Per Share 54275 4
...ncestral line of parasitic bacteria, scientists ca...o revealed where you lived or who you spent time w...ow to look. , Stanford researchers with collabora...dation for opening such a window to the past using...ue uses genomic data to examine metabolic networks...
...cal model could be used to predict an individual,s...hildren,s Hospital Informatics Program (CHIP). Usi... the researchers showed that their predictive mode...ardioembolic stroke -- the most common form of str...reported in the March issue of Stroke . , "For c...
... warning signs of climate change in the upper atmo...e 2009 Tyler Prize for Environmental Achievement. ... and gold medals, will go to Richard Alley, profes...eerabhadran (Ram) Ramanathan, professor of atmosph...on of Oceanography at the University of California...
Other Biology News:Reversing ecology reveals ancient environments 2Predicting risk of stroke from one's genetic blueprint 2Winners of Tyler environmental prize announced 2
...Linear Ion Trap Time of Flight Mass Analyzer for s...power., Specifications:, * MS mode measurement r...range: 150 - 4000 m/z, * Resolution: 14,000 (1400 ...eference, * Dynamic range: 4 orders of magnitude ...
...lay Vector is specifically designed to target and ...charomyces cerevisiae. Displayed proteins can be a...r putative ligands. pYD1 uses the a-agglutinin yea..., Aga1 and Aga2, to display recombinant protein on...
...is a pleiotropic cytokine produced by activated T ...nhibits the growth of some tumour and normal cell ...osis sarcoma cell proliferation, cytokine release ... receptor expression on hepatoma cells. Mouse OSM ...
Mouse Anti-Human BTAF1 Polyclonal Antibody, Unconjugated from Novus Biologicals
Biology Products: